AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://ncbi.nlm.nih.gov/pubmed/24167368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak